home / stock / mgtx / mgtx message board
Subject | By | Source | When |
---|---|---|---|
must see | stockguard | investorshub | 05/02/2023 11:41:04 AM |
$MGTX MomentumIts trading | mcp4 | investorshub | 04/25/2023 8:18:05 PM |
$MGTX must see | mcp4 | investorshub | 04/18/2023 7:07:33 PM |
znewcar1: MGTX 29% v7,7M c18.56 f44,3M H19.17 | znewcar1 | investorshangout | 10/18/2021 8:15:27 PM |
MeiraGTx (NASDAQ:MGTX) Given Buy Rating at Piper Jaffray Companies | stockguard | investorshub | 12/30/2019 9:54:37 PM |
Janssen Pharmaceuticals and MeiraGTx just entered into a | mcp4 | investorshub | 10/19/2018 5:17:08 PM |
Zacks Investment Research downgraded $MGTX from a hold | mcp4 | investorshub | 09/10/2018 1:07:16 PM |
Chardan Capital just rated $MGTX a Buy with | mcp4 | investorshub | 08/24/2018 5:44:35 PM |
Some recent analyst comments on $MGTX: | mcp4 | investorshub | 08/21/2018 1:38:10 PM |
FDA has granted orphan drug designation to MeiraGTx's | mcp4 | investorshub | 08/15/2018 6:32:59 PM |
European Medicines Agency's (EMA) Committee gave MieraGTx a | mcp4 | investorshub | 07/03/2018 7:17:44 PM |
News, Short Squeeze, Breakout and More Instantly...
MeiraGTx Holdings plc Company Name:
MGTX Stock Symbol:
NASDAQ Market:
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene the...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference, being held f...
2024-04-17 00:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...